Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-9.5%
operating margin TTM
-3.81%
revenue TTM
34.23 Million
revenue per share TTM
1.28$
valuation ratios | |
|---|---|
| pe ratio | -68.02 |
| peg ratio | 1.02 |
| price to book ratio | 19.65 |
| price to sales ratio | 6.45 |
| enterprise value multiple | 368.16 |
| price fair value | 19.65 |
profitability ratios | |
|---|---|
| gross profit margin | 51.36% |
| operating profit margin | -3.81% |
| pretax profit margin | -9.22% |
| net profit margin | -9.5% |
| return on assets | -6.39% |
| return on equity | -27.85% |
| return on capital employed | -4.44% |
liquidity ratios | |
|---|---|
| current ratio | 1.63 |
| quick ratio | 1.25 |
| cash ratio | 0.84 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 179.89 |
| operating cycle | 247.79 |
| days of payables outstanding | 152.18 |
| cash conversion cycle | 95.61 |
| receivables turnover | 5.38 |
| payables turnover | 2.40 |
| inventory turnover | 2.03 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.14 |
| long term debt to capitalization | 0.02 |
| total debt to capitalization | 0.12 |
| interest coverage | -0.75 |
| cash flow to debt ratio | 6.54 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.78 |
| cash per share | 1.38 |
| operating cash flow per share | 0.79 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 6.54 |
| short term coverage ratios | 7.68 |
| capital expenditure coverage ratio | 71.99 |
Frequently Asked Questions
When was the last time Eton Pharmaceuticals, Inc. (NASDAQ:ETON) reported earnings?
Eton Pharmaceuticals, Inc. (ETON) published its most recent earnings results on 06-11-2025.
What is Eton Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Eton Pharmaceuticals, Inc. (NASDAQ:ETON)'s trailing twelve months ROE is -27.85%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Eton Pharmaceuticals, Inc. (ETON) currently has a ROA of -6.39%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ETON's net profit margin stand at?
ETON reported a profit margin of -9.5% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ETON's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.63 in the most recent quarter. The quick ratio stood at 1.25, with a Debt/Eq ratio of 0.14.